Patents by Inventor John de Groot
John de Groot has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10866884Abstract: Debugger requests are for debugging a script injected into a web application during a debug session are received. Each of the debugger requests include the same debug session identifier. A different one of the debugger requests is associated with each of the break points set for debugging the script. For each of the debugger requests: a new stateless debugger node is connected with a single stateless target tester node. Stateless debugger nodes and stateless target tester nodes reside inside of the multi-node cloud system. The script is debugged on the same stateless target tester node while the debugging is controlled from a developer computer system that is outside of the multi-node cloud system. After completion of each of the debugger requests: a current stateless debugger node is disconnected, and state stored in the multi-node cloud system used for servicing a current debugger request is destroyed.Type: GrantFiled: December 13, 2019Date of Patent: December 15, 2020Assignee: Oracle International CorporationInventors: John Richard Smiljanic, Henry John Wagner, Sekhar Chandra Korupolu, Michael John De Groot
-
Publication number: 20200117579Abstract: Debugger requests are for debugging a script injected into a web application during a debug session are received. Each of the debugger requests include the same debug session identifier. A different one of the debugger requests is associated with each of the break points set for debugging the script. For each of the debugger requests: a new stateless debugger node is connected with a single stateless target tester node. Stateless debugger nodes and stateless target tester nodes reside inside of the multi-node cloud system. The script is debugged on the same stateless target tester node while the debugging is controlled from a developer computer system that is outside of the multi-node cloud system. After completion of each of the debugger requests: a current stateless debugger node is disconnected, and state stored in the multi-node cloud system used for servicing a current debugger request is destroyed.Type: ApplicationFiled: December 13, 2019Publication date: April 16, 2020Applicant: Oracle International CorporationInventors: John Richard Smiljanic, Henry John Wagner, Sekhar Chandra Korupolu, Michael John De Groot
-
Patent number: 10545853Abstract: A debug session identifier representing a debug session for the web application is stored in local storage. The web application is located in multi-node cloud storage. The local storage resides on a developer computer system that executes outside of the multi-node cloud system. A stateless debugger node and a stateless target tester node are selected from at least one node pool in the multi-node cloud system. The stateless debugger node and the stateless target tester node are separate from each other. An internal connection is provided between the stateless debugger node and the stateless target tester node within the multi-node cloud system based on the debug session identifier during the debug session. The script that is injected into the web application is debugged while the web application executes on the stateless target tester node.Type: GrantFiled: November 6, 2017Date of Patent: January 28, 2020Assignee: Oracle International CorporationInventors: John Richard Smiljanic, Henry John Wagner, Sekhar Chandra Korupolu, Michael John De Groot
-
Publication number: 20190138430Abstract: A debug session identifier representing a debug session for the web application is stored in local storage. The web application is located in multi-node cloud storage. The local storage resides on a developer computer system that executes outside of the multi-node cloud system. A stateless debugger node and a stateless target tester node are selected from at least one node pool in the multi-node cloud system. The stateless debugger node and the stateless target tester node are separate from each other. An internal connection is provided between the stateless debugger node and the stateless target tester node within the multi-node cloud system based on the debug session identifier during the debug session. The script that is injected into the web application is debugged while the web application executes on the stateless target tester node.Type: ApplicationFiled: November 6, 2017Publication date: May 9, 2019Applicant: Oracle International CorporationInventors: John Richard Smiljanic, Henry John Wagner, Sekhar Chandra Korupolu, Michael John De Groot
-
Patent number: 9529702Abstract: An adapter can execute a test script in parallel relative to separate tenant installations in a multi-tenant environment. Such tenant installations can be established within a cloud computing environment. Multiple tenant installations may share some installation components, such as an application server and/or a database, so that these shared installation components are not duplicated. While executing the test script in parallel, the adapter can translate selected values for each test script execution so that those values are distinguished from corresponding values within other test script executions. The values can be translated to reflect the identity of the tenant whose installation the test script execution targets. Furthermore, while executing the test scripts in parallel, the adapter can cause the test script executions to synchronize at specified points within the test script, so that all of the test script executions are guaranteed to have executed to a common point before proceeding.Type: GrantFiled: January 13, 2015Date of Patent: December 27, 2016Assignee: Oracle International CorporationInventors: Ronald van Grinsven, Nagarajender Rao Katoori, Mahesh Bansal, Namita Varma, Shailesh Jain Vinayaka, John Richard Smiljanic, Michael John De Groot
-
Publication number: 20160203074Abstract: An adapter can execute a test script in parallel relative to separate tenant installations in a multi-tenant environment. Such tenant installations can be established within a cloud computing environment. Multiple tenant installations may share some installation components, such as an application server and/or a database, so that these shared installation components are not duplicated. While executing the test script in parallel, the adapter can translate selected values for each test script execution so that those values are distinguished from corresponding values within other test script executions. The values can be translated to reflect the identity of the tenant whose installation the test script execution targets. Furthermore, while executing the test scripts in parallel, the adapter can cause the test script executions to synchronize at specified points within the test script, so that all of the test script executions are guaranteed to have executed to a common point before proceeding.Type: ApplicationFiled: January 13, 2015Publication date: July 14, 2016Inventors: Ronald Van Grinsven, Nagarajender Rao Katoori, Mahesh Bansal, Namita Varma, Shailesh Jain Vinayaka, John Richard Smiljanic, Michael John De Groot
-
Patent number: 8772293Abstract: The invention relates to sulfonamide derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes. More particularly the invention relates to new sulfonamide Nav1.7 inhibitors of formula (I): or pharmaceutically acceptable salts thereof, wherein Z1, Ra, Rb, R1, R2, R3, R4 and R5 are as defined in the description. Nav 1.7 inhibitors are potentially useful in the treatment of a wide range of disorders, particularly pain.Type: GrantFiled: July 8, 2011Date of Patent: July 8, 2014Assignees: Pfizer Limited, Icagen Inc.Inventors: Alan Daniel Brown, Marcel John De Groot, Brian Edward Marron, David James Rawson, Thomas Ryckmans, Robert Ian Storer, Paul Anthony Stupple, Nigel Alan Swain, Christopher William West
-
Patent number: 8685977Abstract: The invention relates to sulfonamide derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes. More particularly the invention relates to a new sulfonamide Nav1.7 inhibitors of formula (I): or a pharmaceutically acceptable salt thereof, wherein Ar1, X, R1, R2, R3, R4 and R5 are as defined in the description. Nav 1.7 inhibitors are potentially useful in the treatment of a wide range of disorders, particularly pain.Type: GrantFiled: July 11, 2011Date of Patent: April 1, 2014Assignee: Pfizer LimitedInventors: Andrew Simon Bell, Alan Daniel Brown, Russell Andrew Lewthwaite, Ian Roger Marsh, David Simon Millan, Manuel Perez Pacheco, David James Rawson, Nunzio Sciammetta, Robert Ian Storer, Paul Anthony Stupple, Nigel Alan Swain, Marcel John De Groot
-
Patent number: 8592629Abstract: This invention relates to sulfonamide derivative of formula (I), to their use in medicine, to compositions containing them, to processes for their preparation, and to intermediates used in such processes. These compounds are inhibitors of Nav1.7.Type: GrantFiled: July 11, 2011Date of Patent: November 26, 2013Assignee: Pfizer LimitedInventors: Andrew Simon Bell, Alan Daniel Brown, Marcel John De Groot, Russell Andrew Lewthwaite, Ian Roger Marsh, David Simon Millan, Manuel Perez Pacheco, David James Rawson, Nunzio Sciammetta, Robert Ian Storer, Nigel Alan Swain, Steven Matthieu Gaulier
-
Patent number: 8328000Abstract: A device which is suitable for processing agricultural products such as bulbous plants, is provided at least with at least a magnetic track comprising a number of magnet segments of alternating polarity. The device is further provided with at least one magnet which is movable with respect to the magnetic track. A function element connected to the magnet is movable in dependence on the position of the magnet relative to the magnet segments of the magnetic track.Type: GrantFiled: March 10, 2010Date of Patent: December 11, 2012Assignee: Dofra B.V.Inventors: John de Groot, Pedro Salcedo, Niek Koerselman, Tim Jaspers
-
Publication number: 20120010207Abstract: The invention relates to sulfonamide derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes. More particularly the invention relates to a new sulfonamide Nav1.7 inhibitors of formula (I): or a pharmaceutically acceptable salt thereof, wherein Ar1, X, R1, R2, R3, R4 and R5 are as defined in the description. Nav 1.7 inhibitors are potentially useful in the treatment of a wide range of disorders, particularly pain.Type: ApplicationFiled: July 11, 2011Publication date: January 12, 2012Applicant: PFIZER LIMITEDInventors: Andrew Simon Bell, Alan Daniel Brown, Russell Andrew Lewthwaite, Ian Roger Marsh, David Simon Millan, Manuel Perez Pacheco, David James Rawson, Nunzio Sciammetta, Robert Ian Storer, Paul Anthony Stupple, Nigel Alan Swain, Marcel John De Groot
-
Publication number: 20120010183Abstract: The invention relates to sulfonamide derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes. More particularly the invention relates to a new sulfonamide Nav1.7 inhibitors of formula (I): or a pharmaceutically acceptable salt thereof, wherein Het1, X, R1, R2, R3, R4 and R5 are as defined in the description. Nav 1.7 inhibitors are potentially useful in the treatment of a wide range of disorders, particularly pain.Type: ApplicationFiled: July 11, 2011Publication date: January 12, 2012Applicant: PFIZER LIMITEDInventors: Andrew Simon Bell, Alan Daniel Brown, Marcel John De Groot, Russell Andrew Lewthwaite, Ian Roger Marsh, David Simon Millan, Manuel Perez Pacheco, David James Rawson, Nunzio Sciammetta, Robert Ian Storer, Nigel Alan Swain, Steven Matthieu Gaulier
-
Publication number: 20120010182Abstract: The invention relates to sulfonamide derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes. More particularly the invention relates to new sulfonamide Nav1.7 inhibitors of formula (I): or pharmaceutically acceptable salts thereof, wherein Z1, Ra, Rb, R1, R2, R3, R4 and R5 are as defined in the description. Nav 1.7 inhibitors are potentially useful in the treatment of a wide range of disorders, particularly pain.Type: ApplicationFiled: July 8, 2011Publication date: January 12, 2012Applicants: ICAGEN INC., PFIZER LIMITEDInventors: Alan Daniel Brown, Marcel John De Groot, Brian Edward Marron, David James Rawson, Thomas Ryckmans, Robert Ian Storer, Paul Anthony Stupple, Nigel Alan Swain, Christopher William West
-
Publication number: 20100230246Abstract: A device which is suitable for processing agricultural products such as bulbous plants, is provided at least with at least a magnetic track comprising a number of magnet segments of alternating polarity. The device is further provided with at least one magnet which is movable with respect to the magnetic track. A function element connected to the magnet is movable in dependence on the position of the magnet relative to the magnet segments of the magnetic track.Type: ApplicationFiled: March 10, 2010Publication date: September 16, 2010Applicant: DOFRA B.V.Inventors: John de Groot, Pedro Salcedo, Niek Koerselman, Tim Jaspers
-
Publication number: 20080025033Abstract: What is disclosed is a vessel (1) provided with one or more light sources (3), wherein the vessel is at least partially made of an at least slightly light-transmitting material, and wherein said at least one light source is connected to the material in such a manner that the light is spread within the material. The advantage of the vessel is that the—usually supporting—material of which the vessel is built up, which material is already present anyway in some types of boats, such as inflatable boats, can be utilized in a multifunctional manner, so that it can be used as a light carrier or a light diffuser as well. As a result, the vessel attracts more attention, but it can also be used more effectively as a conspicuous, eye-catching craft, which makes it optimally suitable for use as, for example, an advertising craft or a warning buoy.Type: ApplicationFiled: January 6, 2005Publication date: January 31, 2008Inventor: John De Groot